Marina A | Drug Development | Clinical Life Science Awards

Prof. Marina A | Drug Development | Clinical Life Science Award

Prof. Marina A | Annamalai University | India

Dr. Marina A., Pharm.D., Ph.D., has established a strong academic and research profile with significant contributions in clinical pharmacy and pharmacology, particularly focusing on polycystic ovary syndrome (PCOS) through randomized controlled trials and high-quality publications. She has authored 1 Scopus-indexed publications, including both research and review articles published in reputed Q1 and Q2 journals such as Inflammopharmacology (IF 5.3), Current Medical Research & Opinion (IF 2.3), European Journal of Obstetrics & Gynecology (IF 2.1), and BMC Nephrology (IF 2.4). Her research has already attracted citations, with her citation count exceeding 120, and she has accumulated a total of 4 Scopus documents, reflecting her growing visibility in the scientific community. Her h-index is 5, which demonstrates not only productivity but also impactful research that is being referenced by peers globally. Alongside publishing, Dr. Marina also serves as a reviewer for respected journals like Reproductive Sciences and Inflammopharmacology, further highlighting her academic credibility. With expertise in regulatory medical writing, teaching, and clinical trial management, she has built a balanced profile bridging academia, industry, and clinical research. Her continuous scholarly output, growing citation base, and expanding peer review roles position her as a promising researcher with strong future potential in life sciences.

Profiles: Scopus | Orcid | LinkedIn

Featured Publications

Marina, A. (in press). Exploring the role of pentoxifylline as a renal protector in diabetic kidney disease: A comprehensive review. BMC Nephrology. Springer Nature. (Q2, IF 2.4, CiteScore 4.1).

Marina, A. (2025). Resveratrol: Potential therapeutic effects on ocular health. Inflammopharmacology, Springer Nature. (Q1, IF 5.3, CiteScore 8.4).

Marina, A. (2025). Effectiveness of acarbose plus metformin and acarbose plus myo-inositol dual combination therapy in alleviating the metabolic and endocrinological complications of PCOS. European Journal of Obstetrics & Gynecology and Reproductive Medicine, Elsevier. (Q2, IF 2.1, CiteScore 4.6).

Marina, A. (2025). Therapeutic potential of acarbose in ameliorating the metabolic and endocrinological complications of polycystic ovarian syndrome: A review. Current Medical Research & Opinion, Taylor & Francis. (Q1, IF 2.3, CiteScore 4.2).

Marina, A. (2025). Clinical implications of acarbose plus myo-inositol therapy on the thyroid profile of women with PCOS. Journal of Pharmacy and Pharmacognosy Research, (Q2, IF 1.2, CiteScore 3.0).

Pratap Mali | Drug Development | Best Researcher Award

Prof. Pratap Mali | Drug Development | Best Researcher Award

University of Rajasthan, Jaipur | India

Dr. Pratap Chand Mali is a Professor in the Department of Zoology, University of Rajasthan, Jaipur, specializing in reproductive biology and physiology with a strong research focus on antifertility effects of medicinal plants and natural products. His academic profile is supported by a notable citation record, with 636 citations, an h-index of 12, and an i10-index of 16, reflecting his scholarly contributions and impact in the field. Over the years, he has authored numerous scientific documents and research articles, many of which explore innovative strategies for fertility regulation, contraceptive development, and reproductive health using phytochemicals and natural extracts. His publications span international journals, conferences, and symposiums, indicating both national and global engagement in advancing reproductive bioscience. In addition to his research, Prof. Mali has played significant editorial roles across multiple reputed journals and has been an invited speaker at high-profile scientific conferences worldwide. His research portfolio demonstrates a consistent dedication to addressing reproductive health challenges while exploring safe, effective, and reversible contraceptive methods. With his substantial output of academic documents, coupled with steady citation growth, Prof. Mali continues to influence the domains of reproductive biology, contraceptive innovation, and natural product pharmacology.

Profiles: Orcid | Scopus

Featured Publication

Targeting IDO1 in Huntington’s Disease: Network Pharmacology and Preclinical Evidence from Coffea arabica